7Baggers
Quarterly
Annual
    Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 
      
    		                           
      cash flows from operating activities
    		                           
      net income
    		-3,240,000 -5,196,000 -6,790,000 -6,998,000 -9,249,000 -6,629,000 -988,000 -7,747,000 -6,302,000 -6,390,000 1,157,000 -27,526,000 -41,131,000 -28,068,000      -32,832,000 -40,393,000 -26,179,000  -23,922,000 -18,036,000 -15,934,000 -14,060,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                           
      depreciation and amortization
    		53,000 71,000 102,000 121,000 153,000 159,000 161,000 168,000 224,000 182,000 230,000 226,000 188,000 195,000  145,000 216,000 130,000  93,000 100,000 86,000  48,000 20,000 19,000 14,000 
      stock-based compensation
    		2,902,000 3,341,000 3,079,000 4,195,000 3,439,000 3,846,000 3,123,000 2,410,000 3,616,000 5,304,000 3,537,000 3,341,000 13,633,000 5,091,000  4,901,000 4,827,000 4,698,000  3,134,000 2,454,000 2,211,000  1,345,000 971,000 864,000 495,000 
      foreign currency transactions
    		-1,940,000 -812,000           1,422,000 311,000  238,000 78,000 435,000  4,000 -91,000 25,000  134,000 -62,000 51,000 -4,000 
      changes in assets and liabilities:
    		                           
      accounts receivable
    		2,000,000 1,948,000 -292,000 2,275,000 -1,603,000 1,866,000 -3,580,000 244,000 -416,000 -6,171,000 -3,280,000 -2,043,000 2,116,000 -1,612,000  1,253,000 -2,520,000 -5,997,000          
      inventories
    		-1,670,000 -724,000 2,343,000 -1,059,000 -50,000 -3,383,000 2,048,000 -1,926,000 3,758,000 -2,243,000 -460,000 552,000 -1,206,000 -76,000  -967,000 -2,815,000 -1,005,000          
      insurance recovery receivable related to legal settlement
    		                           
      other current assets
    		368,000 -30,000 -2,911,000 781,000 1,239,000 1,473,000 -2,654,000 1,269,000 -320,000 1,722,000 -3,279,000 1,699,000 -150,000 1,370,000  646,000 1,291,000 2,993,000  2,381,000 -1,201,000 759,000  1,627,000 -267,000 902,000 -940,000 
      inventories, long-term
    		-751,000 -700,000                          
      other assets
    		72,000 -230,000 5,930,000 -4,906,000 -2,287,000 1,318,000 -3,077,000 2,835,000 -3,587,000 -2,983,000 -80,000 149,000 1,089,000 -3,668,000  42,000 40,000 -1,543,000  -11,000 24,000 -11,000  -74,000 -1,000 -56,000 1,000 
      accounts payable
    		4,877,000 -1,223,000 -3,659,000 -1,132,000 3,230,000 176,000 -660,000 -47,000 -1,378,000 -4,771,000 -1,090,000 2,432,000 -3,370,000 1,109,000  4,221,000 260,000 -2,829,000  495,000 -435,000 1,740,000  -1,984,000 3,149,000 -134,000 -439,000 
      accrued liabilities and other
    		-1,020,000 -3,356,000 3,189,000 863,000 1,569,000 -2,795,000 -1,519,000 1,051,000 -11,000 2,682,000 -5,275,000 -30,000 4,309,000 423,000  303,000 2,804,000 -146,000  2,591,000 3,200,000 -387,000  1,431,000 186,000 805,000 1,356,000 
      accrued legal settlement
    		                           
      net cash from operating activities
    		1,651,000 -6,911,000 -1,870,000 -10,665,000 298,000 -3,477,000 -8,036,000 -1,338,000 -4,734,000 -13,124,000 -8,661,000 -19,235,000 -23,100,000 -24,925,000  -18,076,000 -18,756,000 -31,861,000  -24,145,000 -27,635,000 -21,756,000  -21,395,000 -14,040,000 -13,483,000 -13,577,000 
      capex
    		0 -127,000 0 0 0 0 0 0 0 0 0 0 0 0  -71,000 -41,000 -400,000  -103,000 -2,000 -26,000  -617,000 -75,000 -126,000 -57,000 
      free cash flows
    		1,651,000 -7,038,000 -1,870,000 -10,665,000 298,000 -3,477,000 -8,036,000 -1,338,000 -4,734,000 -13,124,000 -8,661,000 -19,235,000 -23,100,000 -24,925,000  -18,147,000 -18,797,000 -32,261,000  -24,248,000 -27,637,000 -21,782,000  -22,012,000 -14,115,000 -13,609,000 -13,634,000 
      net cash from investing activities
    		0 -127,000                61,610,000  -2,713,000 -2,000 -26,000  -617,000 -75,000 -126,000 -57,000 
      purchase of property and equipment
    		0 -127,000              -71,000 -41,000 -400,000  -103,000 -2,000 -26,000  -617,000 -75,000 -126,000 -57,000 
      cash flows from financing activities
    		                           
      proceeds from exercised stock options
    		332,000 114,000 986,000 979,000 1,758,000 588,000     0 52,000 0 32,000  248,000 131,000 110,000  215,000 0 370,000      
      net cash from financing activities
    		332,000 114,000 986,000 979,000 1,758,000 588,000     0 52,000 0 32,000  248,000 131,000 107,835,000  215,000 0 370,000     -1,842,000 
      effect of exchange rates on cash and cash equivalents
    		   2,000 1,000 1,000 2,000 0 14,000 -9,000 -103,000 44,000 41,000 53,000 52,000 42,000 -18,000 53,000 176,510        24,000 
      net decrease in cash and cash equivalents
    		1,983,000 -6,924,000 -888,000 -9,684,000 2,057,000 -2,888,000 -7,934,000 -1,338,000 -4,720,000 -13,133,000         75,776,498         
      cash and cash equivalents at the beginning of period
    		0 67,234,000 0 0 0 78,637,000 0 0 0 105,762,000 0 0 0 181,564,000  0 0 114,634,000          
      cash and cash equivalents at the end of period
    		1,983,000 60,310,000 -888,000 -9,684,000 2,057,000 75,749,000 -7,934,000 -1,338,000 -4,720,000 92,629,000 -8,764,000 -19,139,000 -23,059,000 156,724,000  -17,857,000 -18,684,000 252,271,000          
      ​
    		                           
      supplemental disclosure of non-cash activities
    		                           
      right-of-use assets obtained in exchange for lease obligations
    		  0 0   0    0             69,000 -1,488,000 2,320,000  
      property and equipment purchase in accrued liabilities and other
    		                           
      foreign currency and other transactions
    		  2,443,000 -1,180,000 232,000 492,000    -456,000 -121,000                 
      benefit from bad debt
    		                           
      cash flows from investing activities
    		                           
      supplemental disclosure of cash flow information
    		                           
      cash paid for income taxes
    		                           
      acquisition of treasury shares upon repayment of secured promissory note
    		                           
      foreign currency transactions and other transactions
    		      -890,000                     
      intangible assets acquisition in accrued liabilities
    		                           
      acquisition of treasury shares upon repayment of secured promissory note – refer to note 10
    		      0 0   0                 
      intangible assets acquisition in accrued milestones and royalty payments
    		            0 1,500,000              
      gain from sale of priority review voucher
    		               0 0 -62,010,000          
      acquisition of intangible assets
    		                           
      net proceeds from sale of priority review voucher
    		               0 0 62,010,000          
      proceeds from issuance of common stock, net of issuance costs
    		               0 0 107,725,000         -1,842,000 
      net increase / (decrease) in cash and cash equivalents
    		          -8,764,000 -19,139,000 -23,059,000 -24,840,000 -34,166,000 -17,857,000 -18,684,000 137,637,000          
      intangible assets acquisition in accrued milestones
    		                           
      property and equipment purchases in accounts payable
    		                 60,000      729,000 -65,000 88,000  
      cash from operating activities
    		                           
      cash from / (used in) investing activities
    		                           
      cash from financing activities
    		                           
      non-cash expense in connection with equity issuance to msk/mit
    		                   0        
      non-cash expense in connection with equity issuance to inventors
    		                   0        
      loans to inventors
    		                           
      net cash provided by/ (used in) investing activities
    		               -71,000            
      net income /
    		                -22,937,000 33,413,000          
      cash from investing activities
    		                           
      effect of exchange rates on cash, cash equivalents and restricted cash
    		                    -78,000 50,000 -34,000 41,000 3,000 13,000  
      net decrease in cash, cash equivalents and restricted cash
    		                    -27,715,000 -21,362,000      
      cash, cash equivalents and restricted cash at the beginning of period
    		                    0 207,136,000  0 0 147,871,000 0 
      cash, cash equivalents and restricted cash at the end of period
    		                    -27,715,000 185,774,000  -21,971,000 -14,112,000 134,275,000 -15,452,000 
      net increase in cash, cash equivalents and restricted cash
    		                        -14,112,000 -13,596,000  
      payment of offering costs for private placement
    		                           
      net increase/(decrease) in cash, cash equivalents and restricted cash
    		                           
      common stock issuance costs in accounts payable
    		                           
      deferred offering costs included in other assets and accounts payable and accrued liabilities and other
    		                           
      payment of offering costs
    		                           
      net increase in cash and cash equivalents
    		                          -15,452,000 
      supplemental disclosure of noncash financing activities
    		                           
      common stock issuance cost in accounts payable
    		                           
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.